References

Epidemiology of renal cell carcinoma: 2022 update

10.1016/j.eururo.2022.08.019 · 2022 · External reference

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

10.3322/caac.21660 · 2021 · External reference

Unresolved reference

2025 · External reference

Molecular imaging of renal cell carcinomas: ready for prime time

10.1038/s41585-024-00962-z · 2025 · External reference

Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT

10.1007/s00259-015-3159-6 · 2016 · External reference

Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma

10.1111/j.1464-410x.2008.08150.x · 2009 · External reference

Imaging in suspected renal-cell carcinoma: systematic review

10.1016/j.clgc.2018.07.024 · 2019 · External reference

[(89)Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial

10.1016/s1470-2045(24)00402-9 · 2024 · External reference

Lesion detection by [(89)Zr]Zr-DFO-girentuximab and [(18)F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma

10.1007/s00259-019-04358-9 · 2019 · External reference

Preclinical and pilot clinical evaluation of a small-molecule carbonic anhydrase IX targeting PET tracer in clear cell renal cell carcinoma

10.1007/s00259-023-06248-7 · 2023 · External reference

Evaluation of the safety, biodistribution, dosimetry of [(18)F]AlF-NYM005 and initial experience in clear cell renal cell carcinoma: an interim analysis of a prospective trial

10.1007/s00259-024-07007-y · 2025 · External reference

First-in-Human safety, imaging, and dosimetry of a carbonic anhydrase IX-targeting peptide, [(68)Ga]Ga-DPI-4452, in patients with clear cell renal cell carcinoma

10.2967/jnumed.123.267175 · 2024 · External reference

Preclinical and first-in-human study of carbonic anhydrase IX-targeting theranostic pair, [(68)Ga]Ga/[(177)Lu]Lu-NYM096, in clear cell renal cell carcinoma

10.2967/jnumed.125.271604 · 2026 · External reference

The CD70-CD27 axis in oncology: the new kids on the block

10.1186/s13046-021-02215-y · 2022 · External reference

Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study

10.1016/s1470-2045(24)00508-4 · 2025 · External reference

A phase 1 trial of SGN-CD70A in patients with CD70-positive, metastatic renal cell carcinoma

10.1002/cncr.31912 · 2019 · External reference

Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents

10.1038/s41591-020-0910-8 · 2020 · External reference

Sensitive CAR T cells redefine targetable CD70 expression in solid tumors

10.1126/science.adv7378 · 2026 · External reference

CD70-Targeted immuno-PET/CT imaging of clear cell renal cell carcinoma: a translational study

10.2967/jnumed.124.268509 · 2024 · External reference

[(18)F]RCCB6 immuno-positron emission tomography/computed tomography for postoperative surveillance in clear cell renal cell carcinoma: a pilot clinical study

10.1016/j.eururo.2024.06.020 · 2024 · External reference

ImmunoPET/CT imaging of clear cell renal cell carcinoma with [(18)F]RCCB6: a first-in-human study

10.1007/s00259-024-06672-3 · 2024 · External reference

[(18)F]RCCB6 immunoPET/CT detects primary clear cell renal cell carcinoma

10.1007/s00259-024-07001-4 · 2025 · External reference

[18F]FDG PET/CT: EANM procedure guidelines for tumour imaging: version 3.0

10.1016/j.eanmj.2025.100006 · 2025 · External reference

Metastatic lesion from clear-cell renal carcinoma after 40 Years and a review of the literature

10.1016/j.clgc.2018.11.018 · 2019 · External reference

Rare metastatic sites of renal cell carcinoma: a case series

10.11604/pamj.2022.42.26.33578 · 2022 · External reference

Skeletal muscle metastasis from renal cell carcinoma: a case series and literature review

10.3389/fsurg.2022.762540 · 2022 · External reference

Skeletal muscle metastasis from a conventional renal cell carcinoma, two years after nephrectomy: a case report

10.1080/00015458.2002.11679332 · 2002 · External reference

Atypical presentations and rare metastatic sites of renal cell carcinoma: a review of case reports

10.1186/1752-1947-5-429 · 2011 · External reference

Value of [(68)Ga]Ga-NYM046 PET/CT, in comparison with (18)F-FDG PET/CT, for diagnosis of clear cell renal cell carcinoma

10.2967/jnumed.124.267527 · 2024 · External reference

Diagnostic efficacy of [(68)Ga]Ga-NY104 PET/CT to identify clear cell renal cell carcinoma

10.1007/s00259-024-06801-y · 2024 · External reference

CD70-targeted allogeneic CAR T-cell therapy for advanced clear cell renal cell carcinoma

10.1158/2159-8290.cd-24-0102 · 2024 · External reference

[18F]AlF-RESCA-R8B4 and [68Ga]Ga-NOTA-R8B4: a pair of novel CD70-targeted ImmunoPET/CT imaging agents for clinical use

10.1021/cbmi.6c00002 · 2026 · External reference

Engineering nanobodies for next-generation molecular imaging

10.1016/j.drudis.2022.03.013 · 2022 · External reference

Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

10.1016/j.annonc.2024.05.537 · 2024 · External reference

Biodistribution and radiation dosimetry of multiple tracers on total-body positron emission tomography/computed tomography

10.21037/qims-22-1418 · 2023 · External reference

Role of F-18 FDG PET/CT in the follow-up of asymptomatic renal cell carcinoma patients for postoperative surveillance: based on conditional survival analysis

10.1007/s00432-021-03688-2 · 2022 · External reference

Current challenges in diagnosis and assessment of the response of locally advanced and metastatic renal cell carcinoma

10.1148/rg.2019180178 · 2019 · External reference

Metastatic renal cell carcinoma: radiologic findings and assessment of response to targeted antiangiogenic therapy by using multidetector CT

10.1148/rg.336125110 · 2013 · External reference

Role of F-18 FDG PET/CT in the follow-up of asymptomatic renal cell carcinoma patients for postoperative surveillance: based on conditional survival analysis

10.1007/s00432-021-03688-2 · 2022 · External reference

testCompareR: an R package to compare two binary diagnostic tests using paired data

10.12688/wellcomeopenres.22411.4 · 2024 · External reference